Actively Recruiting
Early Detection of Pancreatic Ductal Adenocarcinoma Using Blood Tests and Imaging in High-Risk Adults
Led by Dana-Farber Cancer Institute · Updated on 2026-05-29
5000
Participants Needed
2
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating whether adding blood-based tests and symptom reviews to standard pancreatic cancer screening procedures can help detect pancreatic cancer early in people at increased risk. This study focuses on individuals with genetic and family risk factors for pancreatic ductal adenocarcinoma. The research is supported by the Hale Family Research Center at Dana-Farber Cancer Institute and involves a long-term observation phase. Participants will undergo standard screening methods including Endoscopic Ultrasound EUS, Magnetic Resonance Imaging MRI, or Magnetic Resonance Cholangiopancreatography MRCP annually, combined with blood, stool, and saliva sample collections. Blood tests and questionnaires will be completed every six months, with follow-up visits continuing regularly. The study will last a minimum of 30 months and may extend up to 20 years through ongoing medical record reviews and annual sample collection. Participants will complete questionnaires and undergo clinical visits, imaging procedures, and sample collections blood, stool, saliva throughout the study. Researchers will track the number of pancreatic cancers and high-grade pancreatic neoplasms detected, both by imaging and blood assays, and evaluate the predictive value of blood tests over time. Safety and health will be monitored continuously, with assessments occurring every six months for the first three years and follow-up extending up to five years or more.
CONDITIONS
Brief Title
Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals
Research Team
M
Matthew Yurgelun, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here